Page last updated: 2024-09-03

ym 264 and arachidonic acid

ym 264 has been researched along with arachidonic acid in 1 studies

Compound Research Comparison

Studies
(ym 264)
Trials
(ym 264)
Recent Studies (post-2010)
(ym 264)
Studies
(arachidonic acid)
Trials
(arachidonic acid)
Recent Studies (post-2010) (arachidonic acid)
90019,2954863,040

Protein Interaction Comparison

ProteinTaxonomyym 264 (IC50)arachidonic acid (IC50)
60 kDa heat shock protein, mitochondrialHomo sapiens (human)4.5
Fatty acid-binding protein, adipocyteHomo sapiens (human)2.75
10 kDa heat shock protein, mitochondrialHomo sapiens (human)4.5
60 kDa chaperonin Escherichia coli7.3
10 kDa chaperonin Escherichia coli7.3
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)1.0715
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.6026

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bird, IN; Daniels, RH; Elmore, MA; Finnen, MJ; Hill, ME1

Other Studies

1 other study(ies) available for ym 264 and arachidonic acid

ArticleYear
Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers.
    Journal of immunology (Baltimore, Md. : 1950), 1994, Oct-15, Volume: 153, Issue:8

    Topics: Arachidonic Acid; Azepines; Cell Adhesion; Cell Movement; Cell Polarity; Endothelium, Vascular; Humans; In Vitro Techniques; Interleukin-1; Neutrophil Activation; Neutrophils; Piperazines; Platelet Activating Factor; Superoxides; Thiazoles; Thiazolidines; Triazoles

1994